Do you want to read an article? Please log in or register.
Rate of Age-Related Macular Degeneration in Patients Prescribed Glucagon-Like Peptide-1 Receptor Agonists or Other Weight Loss Therapy
Macular Diseases
Related content
Macular Diseases
Glucagon-Like Peptide-1 Receptor Agonists and Age-Related Macular Degeneration
JAMA Ophthalmol
Ahuja AS, Paredes AA 3rd, Young BK
doi: 10.1001/jamaophthalmol.2025.3821
COMMENTED
Macular Diseases
Impact of Glucagon-like Peptide-1 Receptor Agonists on Age-Related Macular Degeneration at a Tertiary Ophthalmology Center
★ 1
Recommended and commented by
Prof. emer. Dr Ulrich Keller, Faculty Member
Ophthalmol Retina
Joo JH, Zhao AH, Chalasani M, Allan KC, Rachitskaya AV
doi: 10.1016/j.oret.2025.12.014
Macular Diseases
Glucagon-Like Peptide-1 Receptor Agonists and Risk of Neovascular Age-Related Macular Degeneration
JAMA Ophthalmol
Shor R, Mihalache A, Noori A, Shor R, Kohly RP, Popovic MM, Muni RH
doi: 10.1001/jamaophthalmol.2025.1455
COMMENTED
Uveitis
Glucagon-Like Peptide-1 Receptor Agonists and Risk of Uveitis
★ 2
Recommended and commented by
Prof. emer. Dr Josef Flammer, Faculty Member
JAMA Ophthalmol
Mohan N, Srivastava SK, Schulgit MJ, Nowacki AS, Kaelber DC, Sharma S
doi: 10.1001/jamaophthalmol.2025.2822
COMMENTED
Retinal Diseases
Ocular Outcomes with Tirzepatide Versus Glucagon-like Peptide-1 Receptor Agonists in Type 2 Diabetes
★ 1
Recommended and commented by
Prof. emer. Dr Ulrich Keller, Faculty Member
Ophthalmol Retina
Hong AT, Lin F, Keenan JD, Stewart JM
doi: 10.1016/j.oret.2026.02.002
Macular Diseases
Association of Mesopic and Dark-Adapted Retinal Sensitivity With Type 1 Macular Neovascularization in Age-Related Macular Degeneration
Invest Ophthalmol Vis Sci
Karaca I, Wei Y, Nelson R, Sassen SH, Daynes K, Clark F, Brown T, Messina A, Pfau M, Zhang Y, Schmitz-Valckenberg S, Fleckenstein M
doi: 10.1167/iovs.66.15.45
Macular Diseases
Ten-Year Incidence, Risk Factors and Progression Rate of Macular Atrophy in Neovascular Age-Related Macular Degeneration
Clin Exp Ophthalmol
Romano F, Casaluci M, Valastro A, Airaldi M, Milella P, Pozzo Giuffrida F, Cozzi E, Aretti A, Teo KY, Cheung CMG, Nassisi M, Viola F, Staurenghi G, Invernizzi A
doi: 10.1111/ceo.14608
Macular Diseases
Cost-minimisation analysis of anti-VEGF therapies in neovascular age-related macular degeneration and diabetic macular oedema in Switzerland
J Med Econ
Ambresin A, Quist SW, Boer M, Maamari S, Barthelmes D
doi: 10.1080/13696998.2025.2536420
Macular Diseases
Vision-related quality of life impact of age-related macular degeneration in older adults aged 60-100 years: a cross-sectional study
Br J Ophthalmol
Vu TA, Fenwick EK, Man REK, Thakur S, Tan ACS, Cheung CMG, Gupta P, Lamoureux EL
doi: 10.1136/bjo-2024-325713